NCT04655755 2026-02-18
Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
Clinical Trials
1 trialsPhase 1/2 × Leukemia, Myelomonocytic, Chronic × decitabine and cedazuridine drug combination × Clear all